FILING ANALYSIS · THURSDAY, OCTOBER 29
PTC THERAPEUTICS, INC. PTCT — 8-K: Results of Operations and Financial Condition
positive
PTC Therapeutics reported strong Q3 2026 financial results with total revenue of $358 million, exceeding expectations, and raised its full-year 2026 revenue guidance to $1.29-$1.32 billion. The company's Sephience revenue grew 20% quarter-over-quarter to $182 million, driving the positive surprise.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →